2006
DOI: 10.1016/j.bbrc.2005.12.186
|View full text |Cite
|
Sign up to set email alerts
|

YHV-protease dsRNA inhibits YHV replication in Penaeus monodon and prevents mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
117
2

Year Published

2011
2011
2019
2019

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 182 publications
(123 citation statements)
references
References 21 publications
4
117
2
Order By: Relevance
“…One observation that has occurred a few times in the literature is the fact that non-target, non-specific dsRNA used as negative controls in viral knockdown experiments has had a protective effect against some viruses including WSSV [154], YHV [207] and even totally unrelated, nonspecific dsRNA (green fluorescent protein) down regulated YHV genes in Penaeus monodon [207]. Similarly, La Fauce and Owens [93] found non-specific dsRNA knocked down against PmergDNV (see above).…”
Section: Non-specific Protective Effects Of Dsrnasmentioning
confidence: 92%
See 2 more Smart Citations
“…One observation that has occurred a few times in the literature is the fact that non-target, non-specific dsRNA used as negative controls in viral knockdown experiments has had a protective effect against some viruses including WSSV [154], YHV [207] and even totally unrelated, nonspecific dsRNA (green fluorescent protein) down regulated YHV genes in Penaeus monodon [207]. Similarly, La Fauce and Owens [93] found non-specific dsRNA knocked down against PmergDNV (see above).…”
Section: Non-specific Protective Effects Of Dsrnasmentioning
confidence: 92%
“…Most authors have delivered the iRNA 24 h before challenge with the virus with satisfactory results. Even up to 4 days but not 5 days administration prior to exposure was protective against YHV [207]. Only one study has shown that delivery of dsRNA 24 h after exposure to YHV was acceptable but 48 h after exposure was too long [143].…”
Section: Dose and Timing Of Prophylactic Delivery Of Rnaimentioning
confidence: 99%
See 1 more Smart Citation
“…The recombinant plasmids were transformed into the E. coli strain HT115, and dsRNAs were purified as described by Yodmuang et al (37). dsRNA was microinjected into Artemia using the Ultra-MicroPump II equipped with a Micro4 TM MicroSyringe pump controller.…”
Section: Methodsmentioning
confidence: 99%
“…The GFP fragment was then subcloned into pET-T7 in a similar manner as ArBAP1. Recombinant plasmids were transformed into E. coli HT115, and dsRNAs were purified as described by Yodmuang et al (2006). A dose gradient (20, 40, 60, 80, and100 ng) of ArBAP1 dsRNA and 100 ng of control GFP dsRNA were injected into the body cavity of Artemia just before ovarian development, with 100 individuals injected for each preparation.…”
Section: In Vitro Enzyme Activity Assaysmentioning
confidence: 99%